Clinical RoundupFree Keytruda significantly prolonged RFS compared to placebo as adjuvant therapy in phase III KEYNOTE-716 Trial August 06, 2021Vol.47 No.31
Clinical RoundupFree International collaboration helps refine treatment for childhood leukemia August 06, 2021Vol.47 No.31
Clinical RoundupFree Comprehensive clinical sequencing opens door to the promise of precision medicine August 06, 2021Vol.47 No.31
Clinical RoundupFree Statins may improve survival for triple-negative breast cancer patients August 06, 2021Vol.47 No.31
Drugs & TargetsFree Opdivo receives EC approval in Esophageal/GEJ indication August 06, 2021Vol.47 No.31
Drugs & TargetsFree FDA grants Priority Review to Tecentriq as adjuvant treatment in NSCLC indication August 06, 2021Vol.47 No.31
Drugs & TargetsFree Cabometyx sNDA receives FDA priority review for previously treated radioactive iodine-refractory differentiated thyroid cancer August 06, 2021Vol.47 No.31
Drugs & TargetsFree BMS issues statement on Istodax relapsed/refractory peripheral T-cell lymphoma U.S. indication August 06, 2021Vol.47 No.31
